Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Diplomat Pharmacy, Inc.    DPLO

DIPLOMAT PHARMACY, INC.

(DPLO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Diplomat Pharmacy : Shares Tumble on UnitedHealth Takeunder

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/09/2019 | 07:18am EST

By Colin Kellaher

Shares of Diplomat Pharmacy tumbled more than 30% in premarket trading Monday after the provider of specialty pharmacy and infusion services agreed to be acquired by UnitedHealth Group for about $303 million, or $4.00 a share, in cash.

The purchase price represents a roughly 31.2% discount to Friday's closing price of $5.81 for Diplomat.

The Flint, Mich., company, which will be merged into UnitedHealth's OptumRx pharmacy-care-services, said its board "carefully considered a variety of strategic options and concluded that joining OptumRx is in the best interests of our shareholders, employees and the clients and patients we serve."

Diplomat said its co-founder and chairman emeritus, Philip Hagerman, along with certain affiliates, have agreed to tender their roughly 23% stake in the company to UnitedHealth in the deal, which is expected to close in early 2020.

Write to Colin Kellaher at colin.kellaher@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
DIPLOMAT PHARMACY, INC. 0.00% 3.99 Delayed Quote.-0.25%
UNITEDHEALTH GROUP -0.38% 299.46 Delayed Quote.1.86%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DIPLOMAT PHARMACY, INC.
2019DIPLOMAT PHARMACY, INC. : Other Events (form 8-K)
AQ
2019DIPLOMAT ALERT : Bragar Eagel & Squire, P.C. Investigates Sale of DPLO and Encou..
PR
2019Monteverde & Associates PC Announces an Investigation of DIPLOMAT PHARMACY, I..
PR
2019ArQule and Fate Therapeutics soar; Sanofi and Diplomat fall
AQ
2019UNITEDHEALTH : plans bargain bid for Diplomat Pharmacy
AQ
2019DIPLOMAT PHARMACY : Shares Tumble on UnitedHealth Takeunder
DJ
2019UNITEDHEALTH : to Buy Diplomat at 31% Discount to Friday's Closing Price
DJ
2019DIPLOMAT PHARMACY, INC. : Entry into a Material Definitive Agreement, Change in ..
AQ
2019Tech Data, Diplomat Pharmacy rise; Helmerich & Payne falls
AQ
2019DIPLOMAT PHARMACY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
More news
Financials (USD)
Sales 2019 4 974 M
EBIT 2019 -0,76 M
Net income 2019 -365 M
Debt 2019 525 M
Yield 2019 -
P/E ratio 2019 -0,82x
P/E ratio 2020 -6,37x
EV / Sales2019 0,17x
EV / Sales2020 0,18x
Capitalization 302 M
Chart DIPLOMAT PHARMACY, INC.
Duration : Period :
Diplomat Pharmacy, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIPLOMAT PHARMACY, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 4,19  $
Last Close Price 3,99  $
Spread / Highest target 25,3%
Spread / Average Target 4,95%
Spread / Lowest Target 0,25%
EPS Revisions
Managers
NameTitle
Brian T. Griffin Chairman & Chief Executive Officer
Dave Loschinskey Chief Operating Officer
Dan Davison Chief Financial Officer & Treasurer
Philip R. Hagerman Chairman-Emeritus
David C. Dreyer Independent Director
Sector and Competitors